MODERATOR
(S):
SPEAKER
(S):
Michael Haller, MD, MS-CI, Assistant Professor, Pediatric Endocrinology, University of Florida
Autologous Cord Blood: Immunotherapy for Type 1 Diabetes?
Joanne Kurtzberg, MD, Professor of Pediatrics and Pathology, Duke University Medical Center
Description
Both within laboratories and at bedsides, cellular therapy has become a promising approach to treating diseases outside of hematologic malignancies. Beyond cell line dysfunctions, cellular therapy is being used to repair tissue, modify immunologic responses and restore cellular metabolic function. This session will provide insight into these emerging therapies utilizing umbilical cord blood. Specifically, this session will address rationales and applications for diabetes mellitus and cerebral palsy.
-
Describe new and emerging uses of umbilical cord blood therapies.
-
Discuss how these non-traditional therapies differ from those using umbilical cord blood for hematopoietic reconstitution.
-
Review the scientific and therapeutic rationale for umbilical cord blood therapy in diabetes mellitus and cerebral palsy.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.